Why Inovio Pharmaceuticals Inc. Is Sinking Today
In response to the company reporting disappointing third-quarter results, shares of Inovio Pharmaceuticals (NASDAQ: INO), a clinical-stage biotech focused on vaccines, fell 14% as of 2:15 p.m. EST on Thursday.
Here's a review of the headline numbers from the quarter:
Looking beyond the financials, here's a quick overview of some of the company's recent clinical news:
Source: Fool.com
Inovio Pharma Stock
€0.53
-2.240%
The sentiment is rather negative at the moment with 6 Sell predictions and 2 Buy predictions.
On the other hand, the target price of 11 € is above the current price of 0.53 € for Inovio Pharma, so the potential is actually 1967.67%.
